{Reference Type}: Journal Article
{Title}: Clinical characteristics and risk factors of severe human parainfluenza virus infection in hospitalized children.
{Author}: Pai MC;Liu YC;Yen TY;Huang KY;Lu CY;Chen JM;Lee PI;Chang LY;Huang LM;
{Journal}: J Microbiol Immunol Infect
{Volume}: 57
{Issue}: 4
{Year}: 2024 Aug 10
{Factor}: 10.273
{DOI}: 10.1016/j.jmii.2024.05.002
{Abstract}: BACKGROUND: Human parainfluenza viruses (HPIVs) commonly cause childhood respiratory illness requiring hospitalization in Taiwan. This study aimed to investigate clinical severity and identify risk factors predisposing to severe disease in hospitalized children with HPIV infection.
METHODS: We included hospitalized patients with lab-confirmed HPIV infection from 2007 to 2018 and collected their demographic and clinical characteristics. Patients with ventilator support, intravenous inotropic agents, and extracorporeal membrane oxygenation were defined as severe cases.
RESULTS: There were 554 children hospitalized for HPIV infection. The median age was 1.2 years; 518 patients had non-severe HPIV infection, whereas 36 patients (6.5%) had severe HPIV infection. 266 (48%) patients had underlying diseases, and 190 patients (34.3%) had bacterial co-detection. Children with severe HPIV infection were more likely to have bacterial co-detection than those without (52.8% vs 33.0%, p = 0.02). Patients with lung patch or consolidation had more invasive bacterial co-infection or co-detection than those without patch or consolidation (43% vs 33%, p = 0.06). Patients with neurological disease (adjusted OR 4.77, 95% CI 1.94-11.68), lung consolidation/patch (adjusted OR 6.64, 95% CI 2.80-15.75), and effusion (adjusted OR 11.59, 95% CI 1.52-88.36) had significantly higher risk to have severe HPIV infection.
CONCLUSIONS: Neurological disease and lung consolidation/patch or effusion were the most significant predictors of severe HPIV infection.